Department of Preventive Medicine, Northwestern University, Chicago, Illinois, United Sates.
The Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United Sates.
Appl Clin Inform. 2021 Mar;12(2):383-390. doi: 10.1055/s-0041-1729164. Epub 2021 May 12.
The study aimed to understand potential barriers to the adoption of health information technology projects that are released as free and open source software (FOSS).
We conducted a survey of research consortia participants engaged in genomic medicine implementation to assess perceived institutional barriers to the adoption of three systems: ClinGen electronic health record (EHR) Toolkit, DocUBuild, and MyResults.org. The survey included eight barriers from the Consolidated Framework for Implementation Research (CFIR), with additional barriers identified from a qualitative analysis of open-ended responses.
We analyzed responses from 24 research consortia participants from 18 institutions. In total, 14 categories of perceived barriers were evaluated, which were consistent with other observed barriers to FOSS adoption. The most frequent perceived barriers included lack of adaptability of the system, lack of institutional priority to implement, lack of trialability, lack of advantage of alternative systems, and complexity.
In addition to understanding potential barriers, we recommend some strategies to address them (where possible), including considerations for genomic medicine. Overall, FOSS developers need to ensure systems are easy to trial and implement and need to clearly articulate benefits of their systems, especially when alternatives exist. Institutional champions will remain a critical component to prioritizing genomic medicine projects.
本研究旨在了解采用作为免费和开源软件(FOSS)发布的健康信息技术项目的潜在障碍。
我们对参与基因组医学实施的研究联盟参与者进行了调查,以评估对三种系统(ClinGen 电子健康记录 (EHR) 工具包、DocUBuild 和 MyResults.org)采用的机构障碍。该调查包括实施研究综合框架 (CFIR) 的八项障碍,以及从对开放式回答的定性分析中确定的其他障碍。
我们分析了来自 18 个机构的 24 个研究联盟参与者的回复。总共有 14 类感知障碍进行了评估,这些障碍与其他观察到的 FOSS 采用障碍一致。最常被感知的障碍包括系统缺乏适应性、机构缺乏实施优先级、缺乏试验性、缺乏替代系统的优势以及复杂性。
除了了解潜在的障碍外,我们还建议采取一些策略来解决这些障碍(在可能的情况下),包括考虑基因组医学。总体而言,FOSS 开发人员需要确保系统易于试用和实施,并需要明确说明其系统的优势,尤其是在存在替代方案的情况下。机构拥护者仍将是优先考虑基因组医学项目的关键组成部分。